Clinical Trial Update: KP-10 and Insulin Secretion in Men [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update examining KP-10 (kisspeptin) effects on insulin secretion in healthy normal men and obese diabetic men; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Obesity

Drugs mentioned

• KP-10 (kisspeptin-10)

Snippet

Sponsor: Quaid-e-Azam University | Conditions: Kisspeptin Action on Insulin in Healthy Normal Men, Kisspeptin Action on Insulin in Obese Diabetic Men | Phase 3 | Status: COMPLETED